Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with social contacts in four communities during the 2007-2008 influenza season.

Epidemiology and infection·2010
Same author

Predictive value of ICD-9-CM codes used in vaccine safety research.

Methods of information in medicine·2008
Same author

Vaccines and autism: evidence does not support a causal association.

Clinical pharmacology and therapeutics·2007
Same author

Immunity to tetanus is protective against the development of multiple sclerosis.

Medical hypotheses·2005
Same author

Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety.

Methods of information in medicine·2004
Same author

Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia.

European journal of cancer (Oxford, England : 1990)·2004

Related Experiment Video

Updated: Jul 25, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

The Vaccine Safety Datalink project.

F DeStefano1,

  • 1National Immunization Program (MS-F34), Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. fxd1@cdc.gov

Pharmacoepidemiology and Drug Safety
|January 23, 2002
PubMed
Summary

The Vaccine Safety Datalink (VSD) monitors vaccine safety using linked health data. This valuable resource provides crucial information on vaccine safety and coverage for millions of Americans.

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization

Background:

  • The Vaccine Safety Datalink (VSD) is a CDC-led collaboration with health maintenance organizations (HMOs).
  • Established in 1990, its primary goal is to rigorously evaluate vaccine safety concerns.
  • It links computerized vaccination and medical outcome data for approximately 6 million individuals.

Purpose of the Study:

  • To rigorously evaluate concerns about vaccine safety.
  • To provide important information on vaccine safety issues.
  • To address other immunization questions, including vaccination coverage and cost-effectiveness.

Main Methods:

  • Prospective collection of linked computerized data on vaccination, medical outcomes, and covariates.
  • Utilizes data from multiple HMOs, initially four, expanding to ten for specific studies.

More Related Videos

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Related Experiment Videos

Last Updated: Jul 25, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

  • Employs cohort study methodology to estimate incidence rates and risks.
  • Main Results:

    • The VSD has provided significant information on various vaccine safety issues.
    • Demonstrated value in assessing vaccine safety and coverage.
    • Expanded methodology successfully used to investigate intussusception following rotavirus vaccination.

    Conclusions:

    • The VSD is a valuable resource for vaccine safety monitoring.
    • Its infrastructure supports research on vaccine safety, coverage, and cost-effectiveness.
    • The VSD methodology is adaptable for investigating specific vaccine safety concerns.